Invetech and AiCella Collaborate to Enhance Cell Therapy with AI
Invetech and AiCella have announced a strategic collaboration to advance cell therapy innovation, as stated in a press release. This partnership aims to integrate AiCella's AI platform with Invetech's automation technology to enhance the development and manufacturing of cell therapies.
The collaboration focuses on embedding AiCella's predictive AI models into the cell therapy production process. This integration is expected to help therapy developers identify critical process parameters earlier, reduce manufacturing variability, and accelerate the path to scalable, patient-ready therapies.
Both companies plan to showcase their joint capabilities at upcoming industry events, including the Meeting on the Mesa in October 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
iReprogram and University of Michigan Launch AI Diabetes Cell Initiative
Xtalks Plans Webinar on AI for Antibody Process Optimization
AstraZeneca and Oracle Partner on AI for Clinical Trials
Inovia Bio Launches Falcon for Drug Development Workflows
INmune Bio and QCi Apply Quantum Computing to XPro Research
Daily AI Brief: the AI news that matters, in your inbox.